Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · IEX Real-Time Price · USD

0.754

-0.051 (-6.34%)

At close: Apr 19, 2024, 4:00 PM

0.741

-0.013 (-1.78%)

After-hours: Apr 19, 2024, 7:55 PM EDT

Citius Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Selling, General & Admin	15.3	11.75	9.84	8.09	6.29	6.45	6.06	3.78	0.95	0.69	Upgrade
Research & Development	14.82	17.66	12.24	8.81	8.6	6.56	2.94	2.93	1.8	0.49	Upgrade
Other Operating Expenses	6.62	3.91	1.45	0.8	0.72	0.78	0.99	0.73	0.49	0	Upgrade
Operating Expenses	36.73	33.32	23.53	17.71	15.6	13.79	9.99	7.45	3.23	1.18	Upgrade
Operating Income	-36.73	-33.32	-23.53	-17.71	-15.6	-13.79	-9.99	-7.45	-3.23	-1.18	Upgrade
Interest Expense / Income	0	0	0.01	0.02	0.02	0.02	0.85	0.01	0.01	0.11	Upgrade
Other Expense / Income	-4.77	-0.25	-0.49	-0.18	-0.05	-1.27	-0.45	0.84	-0.34	-	Upgrade
Pretax Income	-31.97	-33.06	-23.05	-17.55	-15.56	-12.54	-10.38	-8.3	-2.9	-1.29	Upgrade
Income Tax	0.58	0.58	0	0	0	0	0	0	0	0	Upgrade
Net Income	-32.54	-33.64	-23.05	-17.55	-15.56	-12.54	-10.38	-8.3	-2.9	-1.29	Upgrade
Preferred Dividends	1.15	0	1.45	0	0	0	0	0	0	0	Upgrade
Net Income Common	-33.69	-33.64	-24.51	-17.55	-15.56	-12.54	-10.38	-8.3	-2.9	-1.29	Upgrade
Shares Outstanding (Basic)	151	146	109	39	20	11	5	4	2	1	Upgrade
Shares Outstanding (Diluted)	151	146	109	39	20	11	5	4	2	1	Upgrade
Shares Change	3.57%	34.52%	177.28%	94.25%	87.87%	95.75%	51.32%	70.72%	79.27%	5.15%	Upgrade
EPS (Basic)	-0.22	-0.23	-0.23	-0.45	-0.77	-1.17	-1.89	-2.29	-1.37	-1.05	Upgrade
EPS (Diluted)	-0.22	-0.23	-0.23	-0.45	-0.77	-1.17	-1.89	-2.29	-1.37	-1.05	Upgrade
Free Cash Flow	-29.06	-28.36	-24.26	-16.93	-12.44	-11.32	-7.97	-5.9	-2.39	-1.1	Upgrade
Free Cash Flow Per Share	-0.19	-0.19	-0.22	-0.43	-0.62	-1.05	-1.45	-1.63	-1.12	-0.93	Upgrade
EBITDA	-31.77	-32.88	-22.88	-17.38	-15.54	-12.52	-9.53	-8.29	-2.89	-1.18	Upgrade
Depreciation & Amortization	0.19	0.18	0.16	0.15	0	0	0	0	0	0	Upgrade
EBIT	-31.97	-33.06	-23.04	-17.53	-15.55	-12.52	-9.53	-8.29	-2.89	-1.18	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).